Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) is a synthetic biology company that completed its business combination with Soaring Eagle Acquisition Corp., a blank-check vehicle sponsored by Eagle Equity Partners, in September 2021. The Boston-based firm operates a biological platform designed to engineer custom organisms and biosolutions for sectors including pharmaceuticals, agriculture, and specialty chemicals. Ginkgo filed an 8-K with the Securities and Exchange Commission on June 12, 2026, under accession number 0001628280-26-042932, reflecting ongoing reporting obligations as a post-merger public company. For full filing history, SPAC deal data, and real-time analytics on Ginkgo Bioworks and hundreds of other transactions, sign up for SpacDesk at spacdesk.com.